{"transactions":[{"id":730260,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-06-22T20:08:18.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":22371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 17, 2027, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":94973,"source":{"system":"sec-edgar","filing":"0000905148-26-003025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000090514826003025/form4.xml","form_type":"4"}},{"id":733763,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T22:02:59.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service."}],"balance_after":500000,"derivative":{"exercise_price":18.71,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-26-075256","document":"tm2618042-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926075256/tm2618042-8_4seq1.xml","form_type":"4"}},{"id":774644,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-19T01:12:28.000Z","date":"2026-05-18","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":16.88,"value":1012800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $16.59 to $16.97, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is a Trustee of the Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 (the \"Trust\") and may be deemed to have voting and dispositive power over the shares held by the Trust. The reporting person is the Issuer's chief executive officer and Chairman of its board of directors. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":96928,"source":{"system":"sec-edgar","filing":"0001104659-26-063362","document":"tm2615027-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926063362/tm2615027-1_4seq1.xml","form_type":"4"}},{"id":797886,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-29T23:21:02.000Z","date":"2026-04-29","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":17.62,"value":616700.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.56 to $17.67, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1786039,"source":{"system":"sec-edgar","filing":"0001104659-26-051889","document":"tm2613154-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926051889/tm2613154-1_4seq1.xml","form_type":"4"}},{"id":797885,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-29T23:21:02.000Z","date":"2026-04-28","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":18.02,"value":450500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.87 to $18.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1751039,"source":{"system":"sec-edgar","filing":"0001104659-26-051889","document":"tm2613154-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926051889/tm2613154-1_4seq1.xml","form_type":"4"}},{"id":823997,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-01T00:14:23.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":34000,"price":19.31,"value":656540.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $18.84 to $19.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1726039,"source":{"system":"sec-edgar","filing":"0001104659-26-038031","document":"tm2610818-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926038031/tm2610818-1_4seq1.xml","form_type":"4"}},{"id":823996,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-01T00:14:23.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":18.23,"value":364600.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $18.195 to $18.25, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1692039,"source":{"system":"sec-edgar","filing":"0001104659-26-038031","document":"tm2610818-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926038031/tm2610818-1_4seq1.xml","form_type":"4"}},{"id":921410,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:30:13.000Z","date":"2026-02-02","kind":"purchase","planned":false,"acquired":true,"shares":57000,"price":17.96,"value":1023720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.69 to $18.14, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":423155,"source":{"system":"sec-edgar","filing":"0001104659-26-009756","document":"tm264991-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926009756/tm264991-1_4seq1.xml","form_type":"4"}},{"id":941933,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-10T02:42:58.000Z","date":"2026-01-09","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":16.55,"value":331000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $16.05 to $16.87, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":366155,"source":{"system":"sec-edgar","filing":"0001104659-26-002589","document":"tm262858-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926002589/tm262858-1_4seq1.xml","form_type":"4"}},{"id":941932,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-10T02:42:58.000Z","date":"2026-01-08","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":16.3,"value":489000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $15.82 to $16.60, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":346155,"source":{"system":"sec-edgar","filing":"0001104659-26-002589","document":"tm262858-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926002589/tm262858-1_4seq1.xml","form_type":"4"}},{"id":941931,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-10T02:42:58.000Z","date":"2026-01-07","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":16.38,"value":819000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $16.21 to $16.53, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":316155,"source":{"system":"sec-edgar","filing":"0001104659-26-002589","document":"tm262858-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465926002589/tm262858-1_4seq1.xml","form_type":"4"}},{"id":1020755,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-09T21:24:42.000Z","date":"2025-10-07","kind":"purchase","planned":false,"acquired":true,"shares":36928,"price":20.85,"value":769948.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 7, 2025, the Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 (the \"Trust\"), of which the reporting person is a Trustee, entered into a Securities Purchase Agreement, dated as of October 7, 2025, by and among the Issuer and the investors party thereto, pursuant to which the Trust acquired 36,928 shares of common stock at a purchase price of $20.85 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is a Trustee of the Trust and may be deemed to have voting and dispositive power over the shares held by the Trust. The reporting person is the Issuer's chief executive officer and Chairman of its board of directors. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":36928,"source":{"system":"sec-edgar","filing":"0001104659-25-098413","document":"tm2528454-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465925098413/tm2528454-2_4seq1.xml","form_type":"4"}},{"id":1103576,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true}}],"security":"American Depositary Shares","published_at":"2025-06-23T20:11:34.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":10831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 18, 2026, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":72602,"source":{"system":"sec-edgar","filing":"0000905148-25-002219","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000090514825002219/form4.xml","form_type":"4"}},{"id":1113095,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:30:23.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service."}],"balance_after":400000,"derivative":{"exercise_price":11.94,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001104659-25-058914","document":"tm2517684-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465925058914/tm2517684-1_4seq1.xml","form_type":"4"}},{"id":1259229,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-19T21:01:11.000Z","date":"2025-02-18","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":6.67,"value":166750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $6.54 to $6.91, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":266155,"source":{"system":"sec-edgar","filing":"0001104659-25-015145","document":"tm257089-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465925015145/tm257089-1_4seq1.xml","form_type":"4"}},{"id":1342719,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-05T02:03:46.000Z","date":"2024-12-04","kind":"purchase","planned":false,"acquired":true,"shares":45000,"price":9.98,"value":449100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $9.81 to $10.26, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":241155,"source":{"system":"sec-edgar","filing":"0001104659-24-125677","document":"tm2430232-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924125677/tm2430232-1_4seq1.xml","form_type":"4"}},{"id":1342718,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-05T02:03:46.000Z","date":"2024-12-03","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":10.76,"value":269000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $10.73 to $10.88, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":196155,"source":{"system":"sec-edgar","filing":"0001104659-24-125677","document":"tm2430232-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924125677/tm2430232-1_4seq1.xml","form_type":"4"}},{"id":1357030,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-20T22:20:29.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":14.57,"value":36425.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $14.50 to $14.62, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":171155,"source":{"system":"sec-edgar","filing":"0001104659-24-121081","document":"tm2429053-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924121081/tm2429053-1_4seq1.xml","form_type":"4"}},{"id":1357029,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-20T22:20:29.000Z","date":"2024-11-18","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":15,"value":112500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $14.81 to $15.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":168655,"source":{"system":"sec-edgar","filing":"0001104659-24-121081","document":"tm2429053-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924121081/tm2429053-1_4seq1.xml","form_type":"4"}},{"id":1401505,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-20T22:34:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":2633,"price":18.97,"value":49948.01,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $18.35 to $19.24, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1672039,"source":{"system":"sec-edgar","filing":"0001104659-24-101773","document":"tm2424498-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924101773/tm2424498-1_4seq1.xml","form_type":"4"}},{"id":1401504,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-20T22:34:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":2367,"price":17.88,"value":42321.96,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.70 to $18.27, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1669406,"source":{"system":"sec-edgar","filing":"0001104659-24-101773","document":"tm2424498-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924101773/tm2424498-1_4seq1.xml","form_type":"4"}},{"id":1401503,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-20T22:34:18.000Z","date":"2024-09-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":17.89,"value":89450.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.64 to $18.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1667039,"source":{"system":"sec-edgar","filing":"0001104659-24-101773","document":"tm2424498-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924101773/tm2424498-1_4seq1.xml","form_type":"4"}},{"id":1401502,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-20T22:34:18.000Z","date":"2024-09-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":17.91,"value":179100.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.50 to $18.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1662039,"source":{"system":"sec-edgar","filing":"0001104659-24-101773","document":"tm2424498-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924101773/tm2424498-1_4seq1.xml","form_type":"4"}},{"id":1404870,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":1486000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 25% of the underlying shares of common stock on September 12, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service."}],"balance_after":1486000,"derivative":{"exercise_price":17,"expiration_date":"2034-09-11","underlying":"Common Stock","underlying_shares":1486000},"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1404869,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":418996,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":48254},"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1404868,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":3230268,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":372017},"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1404867,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":941088,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":108381},"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1404866,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series Seed Convertible Preferred Stock","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":1428571,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":164523},"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1404865,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":48254,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed solely to correct the previously reported \"Amount of Securities Beneficially Owned Following Reported Transactions.\" This amended Form 4 does not report any new transactions or otherwise modify the transaction details that were previously reported."}],"balance_after":161155,"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1404864,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":372017,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed solely to correct the previously reported \"Amount of Securities Beneficially Owned Following Reported Transactions.\" This amended Form 4 does not report any new transactions or otherwise modify the transaction details that were previously reported."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1652039,"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1404863,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":108381,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed solely to correct the previously reported \"Amount of Securities Beneficially Owned Following Reported Transactions.\" This amended Form 4 does not report any new transactions or otherwise modify the transaction details that were previously reported."}],"balance_after":112901,"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1404862,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-18T00:54:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":164523,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed solely to correct the previously reported \"Amount of Securities Beneficially Owned Following Reported Transactions.\" This amended Form 4 does not report any new transactions or otherwise modify the transaction details that were previously reported."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1280022,"source":{"system":"sec-edgar","filing":"0001104659-24-100765","document":"tm2424157-14_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100765/tm2424157-14_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1406521,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":1486000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 25% of the underlying shares of common stock on September 12, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service."}],"balance_after":1486000,"derivative":{"exercise_price":17,"expiration_date":"2034-09-11","underlying":"Common Stock","underlying_shares":1486000},"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1406520,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":418996,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":48254},"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1406519,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":3230268,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":372017},"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1406518,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":941088,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":108381},"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1406517,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series Seed Convertible Preferred Stock","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":1428571,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":164523},"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1406516,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":48254,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":156635,"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1406515,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":372017,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":536540,"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1406514,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":108381,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":108381,"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1406513,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-17T00:46:04.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":164523,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series Seed Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC (\"Tellus\") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":164523,"source":{"system":"sec-edgar","filing":"0001104659-24-100325","document":"tm2424157-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000110465924100325/tm2424157-12_4seq1.xml","form_type":"4"}},{"id":1472950,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true}}],"security":"American Depositary Shares","published_at":"2024-06-20T21:00:46.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":21253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted shares that vest in full on June 18, 2025, subject to the Reporting Person's continued service as a member of the issuer's board of directors through such vesting date."}],"balance_after":61771,"source":{"system":"sec-edgar","filing":"0000905148-24-001750","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000090514824001750/form4.xml","form_type":"4"}},{"id":1500437,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T23:58:47.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":11000,"derivative":{"exercise_price":21.77,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-24-065543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024065543/ownership.xml","form_type":"4"}},{"id":1672042,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T00:04:43.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":166667,"price":12,"value":2000004.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 166,667 shares of common stock purchased by Tellus BioVentures, LLC (\"Tellus\") from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported are held of record by Tellus. The Reporting Person may be deemed to have voting and dispositive control over the shares held by Tellus. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein."}],"balance_after":1436745,"source":{"system":"sec-edgar","filing":"0000950170-24-007137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024007137/ownership.xml","form_type":"4"}},{"id":1782077,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-14T01:13:10.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 6,500 shares of the Issuer's common stock, which will vest in full on the date that is the earlier of (i) the Issuer's 2024 Annual Meeting of Stockholders and (ii) September 11, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":6500,"derivative":{"exercise_price":11.2,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0000899243-23-018862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924323018862/doc4.xml","form_type":"4"}},{"id":1840930,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2023-06-30T20:06:24.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":18903,"price":26.45,"value":499984.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":40518,"source":{"system":"sec-edgar","filing":"0000950170-23-031100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000095017023031100/ownership.xml","form_type":"4"}},{"id":1849378,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T20:36:04.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest in full on the first anniversary of the grant date, subject to the reporting person's continuous service through such vesting date."}],"balance_after":13700,"derivative":{"exercise_price":1.04,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":13700},"source":{"system":"sec-edgar","filing":"0001062993-23-013828","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000106299323013828/form4.xml","form_type":"4"}},{"id":2234023,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T21:27:21.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.43,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001062993-22-014809","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000106299322014809/form4.xml","form_type":"4"}},{"id":2448099,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-01-05T02:14:16.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":7763,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21615,"source":{"system":"sec-edgar","filing":"0001567619-22-000398","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000156761922000398/doc1.xml","form_type":"4"}},{"id":2686252,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T21:01:12.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":68577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":68577,"derivative":{"exercise_price":1.74,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":68577},"source":{"system":"sec-edgar","filing":"0001429560-21-000005","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000142956021000005/edgar.xml","form_type":"4"}},{"id":2901895,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-01-20T23:37:01.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":3852,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13852,"source":{"system":"sec-edgar","filing":"0000899243-21-002544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228865/000089924321002544/doc4.xml","form_type":"4"}},{"id":3147094,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T21:25:35.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":64103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":64103,"derivative":{"exercise_price":1.05,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":64103},"source":{"system":"sec-edgar","filing":"0001209191-20-029779","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919120029779/doc4.xml","form_type":"4"}},{"id":3523718,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T21:33:26.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.34,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-030527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919119030527/doc4.xml","form_type":"4"}},{"id":3677301,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-04T14:01:36.000Z","date":"2019-02-01","kind":"purchase","acquired":true,"shares":100000,"price":1.02,"value":102000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in several transactions at prices ranging from $1.0196 - $1.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-19-006652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919119006652/doc4.xml","form_type":"4"}},{"id":3690695,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":87873,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":55.84,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":87873},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690694,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":24260,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":178.95,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":24260},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690693,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":43.39,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690692,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":140000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":55.11,"expiration_date":"2025-03-06","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690691,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":33.74,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690690,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":24.18,"expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690689,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":371428,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":6.615,"expiration_date":"2022-03-16","underlying":"Common Stock","underlying_shares":371428},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690688,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":314285,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":1.33,"expiration_date":"2021-07-19","underlying":"Common Stock","underlying_shares":314285},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690687,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690686,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":10007,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10007},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690685,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690684,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"other","acquired":false,"shares":5000,"price":75,"value":375000.0,"ownership":{"direct":false,"nature":"By The Leon Moulder Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation (\"Purchaser\") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales (\"Parent\"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation (\"TESARO\"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the \"Merger Agreement\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3690683,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-22T09:57:16.000Z","date":"2019-01-22","kind":"other","acquired":false,"shares":1034664,"price":75,"value":77599800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation (\"Purchaser\") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales (\"Parent\"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation (\"TESARO\"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the \"Merger Agreement\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001123292-19-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000169/edgar.xml","form_type":"4"}},{"id":3927885,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T21:08:33.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.84,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-031030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919118031030/doc4.xml","form_type":"4"}},{"id":4015222,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-05T17:27:39.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":87873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in 48 equal monthly installments beginning on April 1, 2018."}],"balance_after":87873,"derivative":{"exercise_price":55.84,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":87873},"source":{"system":"sec-edgar","filing":"0001104659-18-014890","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014890/a4.xml","form_type":"4"}},{"id":4015221,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-03-05T17:27:39.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in four equal annual installments beginning on March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in four equal annual installments beginning on March 1, 2019."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-18-014890","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014890/a4.xml","form_type":"4"}},{"id":4015220,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-03-05T17:27:39.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":3336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on March 1, 2017, and the remaining RSUs vest in three equal annual installments on each of March 1, 2019, 2020 and 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on March 1, 2017, and the remaining RSUs vest in three equal annual installments on each of March 1, 2019, 2020 and 2021."}],"balance_after":10007,"derivative":{"underlying":"Common Stock","underlying_shares":3336},"source":{"system":"sec-edgar","filing":"0001104659-18-014890","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014890/a4.xml","form_type":"4"}},{"id":4015219,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-03-05T17:27:39.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were granted on March 1, 2016, and the remaining RSUs vest in two equal annual installments on each of March 1, 2019 and 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were granted on March 1, 2016, and the remaining RSUs vest in two equal annual installments on each of March 1, 2019 and 2020."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-18-014890","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014890/a4.xml","form_type":"4"}},{"id":4015218,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-05T17:27:39.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":3336,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1034664,"source":{"system":"sec-edgar","filing":"0001104659-18-014890","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014890/a4.xml","form_type":"4"}},{"id":4015217,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-05T17:27:39.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1031328,"source":{"system":"sec-edgar","filing":"0001104659-18-014890","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014890/a4.xml","form_type":"4"}},{"id":4015174,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-05T06:05:08.000Z","date":"2018-03-02","kind":"purchase","acquired":true,"shares":1000,"price":57.14,"value":57140.0,"ownership":{"direct":false,"nature":"By The Leon Moulder Revocable Trust"},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001104659-18-014576","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014576/a4.xml","form_type":"4"}},{"id":4015173,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-05T06:05:08.000Z","date":"2018-03-02","kind":"purchase","acquired":true,"shares":1000,"price":56.89,"value":56890.0,"ownership":{"direct":false,"nature":"By The Leon Moulder Revocable Trust"},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001104659-18-014576","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014576/a4.xml","form_type":"4"}},{"id":4015172,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-05T06:05:08.000Z","date":"2018-03-02","kind":"purchase","acquired":true,"shares":1000,"price":56.88,"value":56880.0,"ownership":{"direct":false,"nature":"By The Leon Moulder Revocable Trust"},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-18-014576","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014576/a4.xml","form_type":"4"}},{"id":4015171,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-05T06:05:08.000Z","date":"2018-03-02","kind":"purchase","acquired":true,"shares":1000,"price":56.87,"value":56870.0,"ownership":{"direct":false,"nature":"By The Leon Moulder Revocable Trust"},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001104659-18-014576","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014576/a4.xml","form_type":"4"}},{"id":4015170,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-05T06:05:08.000Z","date":"2018-03-02","kind":"purchase","acquired":true,"shares":1000,"price":56.86,"value":56860.0,"ownership":{"direct":false,"nature":"By The Leon Moulder Revocable Trust"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001104659-18-014576","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918014576/a4.xml","form_type":"4"}},{"id":4291012,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-06T20:44:19.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":3.08,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-038141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429560/000120919117038141/doc4.xml","form_type":"4"}},{"id":4404086,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-03T17:18:13.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":24260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in 48 equal monthly installments beginning on April 1, 2017."}],"balance_after":24260,"derivative":{"exercise_price":178.95,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":24260},"source":{"system":"sec-edgar","filing":"0001104659-17-014112","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917014112/a4.xml","form_type":"4"}},{"id":4404085,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-03T17:18:13.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":13343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2018."}],"balance_after":13343,"derivative":{"underlying":"Common Stock","underlying_shares":13343},"source":{"system":"sec-edgar","filing":"0001104659-17-014112","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917014112/a4.xml","form_type":"4"}},{"id":4404084,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-03T17:18:13.000Z","date":"2016-03-01","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on March 1, 2016 and vest in four equal annual installments beginning on March 1, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on March 1, 2016 and vest in four equal annual installments beginning on March 1, 2017."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-17-014112","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917014112/a4.xml","form_type":"4"}},{"id":4404083,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-03T17:18:13.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1018828,"source":{"system":"sec-edgar","filing":"0001104659-17-014112","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917014112/a4.xml","form_type":"4"}},{"id":4404082,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":36288,"kind":"person","name":"MOULDER LEON O JR","position":1,"cik":"0001228865","reported_name":"MOULDER LEON O JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-03T17:18:13.000Z","date":"2016-06-24","kind":"gift","acquired":false,"shares":100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person gifted these shares to a family member for no consideration."}],"balance_after":1006328,"source":{"system":"sec-edgar","filing":"0001104659-17-014112","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465917014112/a4.xml","form_type":"4"}}]}